Clinical Trial

Effect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace

Recruiting Phase 4

Record status

This record was last updated August 12, 2025 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.

Summary

As baby grows inside the womb of mother, heart and other organs develop. The heart activity can be recorded by placing a transducer on the belly of mother. The tracing obtain provides information about heart rate, any increase or decrease in heart rate and how much it varies with time. Variation in heart rate along with increase is indicator of fetal well being. Some mothers are at high risk of pre-term birth that is baby delivery before 37 weeks of gestation. In such cases steroids are given to mother to accelerate lung development of the baby so that it can easily adapt to outside world. Dexamethasone and Betamethasone are commonly used steroids which can also effect fetal heart activity.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-07-12; most recent amendment 2025-08-07.

Status change: Active, Not Recruiting → Recruiting 2025-08-07

Trial Details

NCT Number	NCT07078786
Lead Sponsor	Rawalpindi Medical College Collaborators: Rawalpindi Medical College, Pakistan
Conditions	Cardiotocography, Steroids
Enrollment	110 participants
Start Date	2025-07-13
Primary Completion	2025-10-15 (estimated)
Study Completion	2025-10-15 (estimated)
Updated on ClinicalTrials.gov	2025-08-12